Findings from University of California San Francisco (UCSF) Reveals New Findings on Rectal Cancer [Safety of High-dose Rate (Hdr) Brachytherapy for Patients With Prostate Cancer and History of Prior Chemoradiation for Rectal Cancer: a Case ...]

MLA

“Findings from University of California San Francisco (UCSF) Reveals New Findings on Rectal Cancer [Safety of High-Dose Rate (Hdr) Brachytherapy for Patients With Prostate Cancer and History of Prior Chemoradiation for Rectal Cancer: A Case ...].” Health & Medicine Week, 7 June 2024, p. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.796040241&authtype=sso&custid=ns315887.

APA

Findings from University of California San Francisco (UCSF) Reveals New Findings on Rectal Cancer [Safety of High-dose Rate (Hdr) Brachytherapy for Patients With Prostate Cancer and History of Prior Chemoradiation for Rectal Cancer: a Case ...]. (2024, June 7). Health & Medicine Week, 2018.

Chicago

Health & Medicine Week. 2024. “Findings from University of California San Francisco (UCSF) Reveals New Findings on Rectal Cancer [Safety of High-Dose Rate (Hdr) Brachytherapy for Patients With Prostate Cancer and History of Prior Chemoradiation for Rectal Cancer: A Case ...],” June 7. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.796040241&authtype=sso&custid=ns315887.